A damning report led by The Lancet last year found the average person in the UK consumes over half of their daily calories through UPFs
However, individual responses vary significantly
As mentioned earlier, higher doses yield quicker results but may also increase the risk of side effects
To remain competitive, drug developers must double down on data driven decision making, always-on IP surveillance, rigorous safety validation, and early diversification into new modalities and indications
Amber containers or foil covering, short bench time, and discarding solution that has discoloured are all justified
The dramatic improvements in liver fat and metabolic markers observed with retatrutide would be expected to translate into cardiovascular benefits